CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $202,000 | -99.5% | 5,971 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $37,215,000 | +10.1% | 1,591,061 | +35.6% | 0.04% | 0.0% |
| Q4 2020 | $33,790,000 | +69.4% | 1,173,248 | +19.2% | 0.04% | +46.2% |
| Q3 2020 | $19,944,000 | -13.1% | 984,422 | +28.9% | 0.03% | -16.1% |
| Q2 2020 | $22,947,000 | -44.2% | 763,608 | -41.6% | 0.03% | -11.4% |
| Q1 2020 | $41,128,000 | +38700.0% | 1,308,570 | +58084.5% | 0.04% | – |
| Q4 2019 | $106,000 | +960.0% | 2,249 | +46.7% | 0.00% | – |
| Q3 2019 | $10,000 | -99.0% | 1,533 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $957,000 | – | 142,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |